ReviewCureus2025
AI in Radiation Oncology: A Comprehensive Review of Current Applications and Future Directions.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- From Cellular Radiosensitivity to Precision Radiotherapy: Integrating Functional Assays, Genomics, and Clinical Modeling.Cancers · 2026Review
- The evolving physician-AI relationship: a five-tier framework for integrating intelligent systems into clinical practice and medical education.ESMO real world data and digital oncology · 2026Review
- Towards an accessible, centralised, searchable database for AI courses in Europe: the Artificial Intelligence in Medical Imaging and Radiation Oncology Education (AIMIROE) project.European radiology experimental · 2026Article
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
At its core, radiation oncology uses knowledge and expertise from multiple precise disciplines such as physics, mathematics, and computer science, which converge with biology and medicine. This is why the rapidly developing AI use in medicine has immense potential in radiotherapy at different levels, such as image reconstruction, volumetric segmentation, radiotherapy delivery, and treatment response. In this review, we aim to provide a summary of current AI use in radiation oncology, mapping in which areas these tools have already been incorporated, as well as their contributions to radiotherapy workflow. Here, we analyze how machine learning software increases the efficiency and accuracy of radiation treatment planning, delivery, and outcome prediction, providing a comprehensive picture of the advancements, limitations, and future directions of AI use in radiotherapy. The radiotherapy workflow consists of multiple intensive steps that are crucial to planning individualized treatment. The introduction of AI assures quality and standardization and reduces variability and time spent in processes such as image reconstruction, segmentation, and dose calculation. Deep learning segmentation reduces planning and delivery time without sacrificing quality. AI predictive capabilities enable clinicians to anticipate and reduce treatment-related toxicities through accuracy based on clinical parameters and image data. Building powerful models requires extensive and robust high-quality data that maintains privacy and HIPAA compliance and must be collected with precision and accuracy. This process, however, can present ethical and logistical obstacles, such as clinical validation needs and reproducibility standards that must be addressed to fully integrate AI into clinical workflows alongside human oversight.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.